Edward H. Snyder

Patient preferences and utilities for ‘off-time’ outcomes in the treatment of Parkinson's disease

Cynthia S. Palmer, Jordana K. Schmier, Edward H. Snyder et al. · Quality of Life Research · 2000 · 50 citations

Pharmacy, Neurology, Pharmacoeconomics +8

Cost Effectiveness of Treatment of Parkinson??s Disease with Entacapone in the United States

Cynthia S. Palmer, Mark Nuijten, Jordana K. Schmier et al. · PharmacoEconomics · 2002 · 44 citations

Medicine, Pharmacoeconomics, Pharmacology +16

Impact of Rivastigmine on Costs and on Time Spent in Caregiving for Families of Patients With Alzheimer’s Disease

Deborah B. Marin, Karine Amaya, Roman Casciano et al. · International Psychogeriatrics · 2003 · 43 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Influence of Methodology upon Apparent Concentrations of Antibiotics in Tissue

J. Martin Kaplan, George H. McCracken, Edward H. Snyder · Antimicrobial Agents and Chemotherapy · 1973 · 37 citations · Full text

Life Sciences, Microbiology, Antimicrobial Pharmacology +7

Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization

Kristin M. Richards, Marvin D. Shepherd, M. Lynn Crismon et al. · Clinical Therapeutics · 2000 · 23 citations

Medicine, Geriatric Medicine, Health Services Administration +16